JP2024524215A5 - - Google Patents
Info
- Publication number
- JP2024524215A5 JP2024524215A5 JP2023578919A JP2023578919A JP2024524215A5 JP 2024524215 A5 JP2024524215 A5 JP 2024524215A5 JP 2023578919 A JP2023578919 A JP 2023578919A JP 2023578919 A JP2023578919 A JP 2023578919A JP 2024524215 A5 JP2024524215 A5 JP 2024524215A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- protected
- piperidine
- groups
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202141028180 | 2021-06-23 | ||
| IN202141028180 | 2021-06-23 | ||
| PCT/EP2022/067126 WO2022268935A2 (en) | 2021-06-23 | 2022-06-23 | Novel process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524215A JP2024524215A (ja) | 2024-07-05 |
| JP2024524215A5 true JP2024524215A5 (enExample) | 2025-06-27 |
Family
ID=82458485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023578919A Pending JP2024524215A (ja) | 2021-06-23 | 2022-06-23 | Ｎｌｒｐ３阻害剤を調製するための方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240150291A1 (enExample) |
| EP (1) | EP4359385A2 (enExample) |
| JP (1) | JP2024524215A (enExample) |
| KR (1) | KR20240024842A (enExample) |
| CN (1) | CN118019727A (enExample) |
| AR (1) | AR126215A1 (enExample) |
| AU (1) | AU2022300325A1 (enExample) |
| CA (1) | CA3219597A1 (enExample) |
| IL (1) | IL308071A (enExample) |
| MX (1) | MX2023014547A (enExample) |
| TW (1) | TW202317514A (enExample) |
| WO (1) | WO2022268935A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023220628A1 (en) * | 2022-02-15 | 2024-05-23 | F. Hoffmann-La Roche Ag | Processes for the preparation of 1,2,3,5,6,7-hexahydro-s-indacene derivatives |
| WO2024133610A1 (en) * | 2022-12-23 | 2024-06-27 | F. Hoffmann-La Roche Ag | Proccesses for the preparation of an nlrp3 inhibitor |
| WO2025036914A1 (en) | 2023-08-16 | 2025-02-20 | F. Hoffmann-La Roche Ag | Process for the preparation of preparing 1-ethyl-n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)piperidine-4-sulfonamide |
| WO2025153532A1 (en) | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA917435B (en) * | 1990-09-26 | 1992-05-27 | Takeda Chemical Industries Ltd | Herbicides |
| CA2059450A1 (en) * | 1991-01-24 | 1992-07-25 | Nobuyuki Sakashita | Subsituted pyridinesulfonamide compound or its salt, process for preparing the same, and herbicide containing the same |
| JP2001518069A (ja) * | 1997-05-02 | 2001-10-09 | ドクター・レディーズ・リサーチ・ファウンデーション | 低脂質性、抗高血圧性特性を有する新規な抗糖尿病化合物、それらの製造方法及びそれらを含有する薬学的組成物 |
| ATE342266T1 (de) * | 2000-11-16 | 2006-11-15 | Sankyo Co | 1-methylcarbapenemderivate |
| US7199147B2 (en) * | 2001-06-12 | 2007-04-03 | Dainippon Sumitomo Pharma Co., Ltd. | Rho kinase inhibitors |
| MXPA04010172A (es) * | 2002-04-18 | 2005-02-03 | Schering Corp | 1-(4-piperidinil)benzimidazolonas como antagonistas de histamina h3). |
| US7759387B2 (en) * | 2003-10-08 | 2010-07-20 | Piramal Life Sciences Limited | Fibrinogen receptor antagonists and their use |
| DOP2006000009A (es) * | 2005-01-13 | 2006-08-15 | Arena Pharm Inc | Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina |
| US8614215B2 (en) * | 2007-02-22 | 2013-12-24 | Merck Serono Sa | Quinoxaline inhibitors of phosphoinositide-3-kinases (PI3Ks) |
| US20120196889A1 (en) * | 2009-02-25 | 2012-08-02 | H. Lundbeck A/S | Catecholamine derivatives and prodrugs thereof |
| JP5898962B2 (ja) * | 2012-01-11 | 2016-04-06 | 東京応化工業株式会社 | レジスト組成物及びレジストパターン形成方法 |
| EP3383853B1 (en) * | 2015-12-01 | 2020-11-04 | Merck Sharp & Dohme Corp. | Homobispiperidinyl derivatives as liver x receptor (lxr) beta agonists for treating e.g. alzheimer's disease |
| KR102669722B1 (ko) * | 2017-07-07 | 2024-05-29 | 인플라좀 리미티드 | 신규한 설폰아마이드 카복스아마이드 화합물 |
| GB201712282D0 (en) * | 2017-07-31 | 2017-09-13 | Nodthera Ltd | Selective inhibitors of NLRP3 inflammasome |
| SG11202001164SA (en) * | 2017-08-15 | 2020-03-30 | Inflazome Ltd | Novel sulfonamide carboxamide compounds |
| KR20210018199A (ko) * | 2018-03-26 | 2021-02-17 | 씨4 테라퓨틱스, 인코포레이티드 | 이카로스의 분해를 위한 세레블론 결합제 |
| MA52489A (fr) * | 2018-05-04 | 2021-03-10 | Inflazome Ltd | Nouveaux composés |
| CA3113573A1 (en) * | 2018-09-21 | 2020-03-26 | Novartis Ag | Isoxazole carboxamide compounds and uses thereof |
| GB201817038D0 (en) | 2018-10-19 | 2018-12-05 | Inflazome Ltd | Novel processes |
| GB201819083D0 (en) * | 2018-11-23 | 2019-01-09 | Inflazome Ltd | Novel compounds |
| WO2020157069A1 (en) * | 2019-01-28 | 2020-08-06 | NodThera Limited | Amino heterocyclic compounds and uses thereof |
| CN111393415B (zh) * | 2020-04-30 | 2020-11-20 | 苏州信诺维医药科技有限公司 | 一种杂芳腈类化合物及其应用 |
-
2022
- 2022-06-23 MX MX2023014547A patent/MX2023014547A/es unknown
- 2022-06-23 TW TW111123528A patent/TW202317514A/zh unknown
- 2022-06-23 EP EP22738569.7A patent/EP4359385A2/en active Pending
- 2022-06-23 JP JP2023578919A patent/JP2024524215A/ja active Pending
- 2022-06-23 KR KR1020237044161A patent/KR20240024842A/ko active Pending
- 2022-06-23 WO PCT/EP2022/067126 patent/WO2022268935A2/en not_active Ceased
- 2022-06-23 AR ARP220101651A patent/AR126215A1/es unknown
- 2022-06-23 CA CA3219597A patent/CA3219597A1/en active Pending
- 2022-06-23 AU AU2022300325A patent/AU2022300325A1/en active Pending
- 2022-06-23 CN CN202280045202.0A patent/CN118019727A/zh active Pending
- 2022-06-23 IL IL308071A patent/IL308071A/en unknown
-
2023
- 2023-12-19 US US18/545,711 patent/US20240150291A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024099041A5 (enExample) | ||
| JP2014523916A (ja) | Ｎ−置換環状アルキレン尿素を合成する方法 | |
| WO1998046231A1 (en) | Muscarinic agonist compounds | |
| JP4061018B2 (ja) | ウレイドのｎ−アルキル化のための方法及び試薬 | |
| AU2010289802B2 (en) | Synthesis of a neurostimulative piperazine | |
| KR20160095161A (ko) | 포스파티딜이노시톨 3-키나제 억제제의 가공 방법 | |
| Hazarika et al. | Facile, catalyst-free cascade synthesis of sulfonyl guanidines via carbodiimide coupling with amines | |
| KR102708701B1 (ko) | 벤즈이미다졸 유도체의 제조방법 | |
| JP2002534409A5 (enExample) | ||
| JP2004517897A (ja) | テモゾロミドおよびアナログの合成 | |
| CA2264298A1 (en) | Catalytic selective sulfonylation process | |
| JP2025506671A5 (enExample) | ||
| KR100538958B1 (ko) | 4(5)-아미노-5(4)-카르복사미도이미다졸 및 그의 중간체의 제조방법 | |
| CN113087689A (zh) | 5-氨基-γ-内酯衍生物的简便合成方法 | |
| RU2024101439A (ru) | Новый способ | |
| FI60704B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbar 2,6-dimetyl-3-metoxikarbonyl-4-(2'-nitrofenyl)-1,4-dihydropyridin-5-karboxylsyraisobutylester | |
| US20040024217A1 (en) | Synthesis of piperidine and piperazine compounds as CCR5 antagonists | |
| US6730796B2 (en) | Process for preparation of N-substituted 2-sulfanylimidazoles | |
| JPWO2018043215A1 (ja) | チオグリコールウリル類及びその製造方法 | |
| US3905992A (en) | N,N{40 -alkylenebis(2-amino-1-(2-imidazolin-2-yl)-2-imidazolines) | |
| US3278542A (en) | ||
| CN112409116B (zh) | 一种胺基脂肪族硒氰酸酯类化合物的制备方法 | |
| KR101416077B1 (ko) | 로듐 촉매를 이용한 분자간 탄소-질소 교차 짝지움 반응을 통한 아릴아민 화합물의 제조방법 | |
| CN102127031B (zh) | 一种麻黄碱类化合物季胺盐及其合成方法和应用 | |
| RU2025120242A (ru) | Способы получения ингибитора nlrp3 |